trending Market Intelligence /marketintelligence/en/news-insights/trending/JY3HujrMvehrAd9Vf6QEMw2 content esgSubNav
In This List

Clementia prices IPO

Blog

Gauging Supply Chain Risk In Volatile Times

Blog

Insight Weekly: Banks' efficiency push; vacuuming carbon; Big Pharma diversity goals

Blog

The Future of Risk Management Digitization in Credit Risk Management

Blog

Climate Credit Analytics: Diving into the model


Clementia prices IPO

Clementia Pharmaceuticals Inc. priced its IPO of 8 million common shares at $15 per share.

The company also granted underwriters a 30-day option to buy up to an additional 1.2 million of the shares offered.

The shares will begin trading on the Nasdaq Global Select Market on Aug. 2 under the CMTA symbol. The offering is expected to close on Aug. 7.

Morgan Stanley & Co. LLC and Leerink Partners LLC are acting as book-running managers for the offering, while Wedbush Securities Inc. and BTIG LLC are acting as co-managers.